Search for: "Medical Technology Associates, Inc." Results 741 - 760 of 1,119
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Dec 2011, 8:03 am by Theodore J. Kobus III
  The second incident involved a $4.3M penalty against Cignet for refusing to provide 41 patients access to medical records. [read post]
28 Dec 2011, 12:00 am by RegBlog
 The FTC sought to prevent Laboratory Corporation of America (LabCorp) from acquiring Westcliff Medical Laboratories, Inc. [read post]
19 Dec 2011, 1:38 pm by Antoinette Konski
Prometheus Laboratories, Inc., (reported in our December 7th post) the American Civil Liberties Union Foundation (“ACLU”) and the Public Patent Foundation petitioned the U.S. [read post]
21 Nov 2011, 11:53 am by Stephen Jenei
., Inc, Supreme Court No. 10-1150, to consider whether to set limits on when inventors can patent medical diagnostic tests. [read post]
12 Nov 2011, 12:56 pm by Rebecca Tushnet
Regulation needs to move beyond social networks to medical profiles. [read post]
31 Oct 2011, 7:00 am by Joshua Matz
Bausch (patient lawsuits against medical-device makers). [read post]
28 Oct 2011, 2:00 am by Stefanie Levine
Patent No. 7,704,921 entitled PRODUCTION OF ACTIVATED CHAR USING HOT GAS  and owned by Praxair Technology, Inc. [read post]
28 Oct 2011, 2:00 am by Stefanie Levine
Patent No. 7,704,921 entitled PRODUCTION OF ACTIVATED CHAR USING HOT GAS  and owned by Praxair Technology, Inc. [read post]
25 Oct 2011, 7:11 am by Hopkins
Steinbrook notes that conflicts of interest continue as recently reported in The Spine Journal, in connection with a Medtronic clinical trial for recombinant bone morphogenetic protein: “Financial information was available for 12 of the 13 original studies: “the median-known financial associations between the authors and Medtronic Inc were found to be approximately $12,000,000 to $16,000,000 per study (range, $560 000-$23 500 000). [read post]
25 Oct 2011, 7:11 am by Hopkins
Steinbrook notes that conflicts of interest continue as recently reported in The Spine Journal, in connection with a Medtronic clinical trial for recombinant bone morphogenetic protein: “Financial information was available for 12 of the 13 original studies: “the median-known financial associations between the authors and Medtronic Inc were found to be approximately $12,000,000 to $16,000,000 per study (range, $560 000-$23 500 000). [read post]
3 Oct 2011, 7:10 am by Cynthia Marcotte Stamer
    Her experience includes extensive experience  advising insured and self-insured ERISA group medical and other plans,  Medicare and Medicaid Advantage plans, mini-med, high-deductible and other consumer driven medical, long-term care, occupational injury, ex-pat, association, fraternal benefit and other managed care and medical benefit plans and insurers, their service providers,  insurers,  sponsors, fiduciaries,… [read post]
23 Sep 2011, 12:50 pm by Cara Disisto
About Graeser Associates International, Inc: Based in Chicago, GAI is an international intellectual property and business consulting firm, specializing in biotech, medical devices and pharmaceuticals. [read post]